Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Liquid-Ready QC Solution for POC Urinalysis Instruments Helps Labs Streamline Daily Operations

By LabMedica International staff writers
Posted on 23 Jan 2023

Healthcare and laboratory professionals need to ensure consistent and accurate results. Now, a liquid-ready urinalysis solution for use with point-of-care urinalysis instruments and reagents, including 12 parameters and hCG, aims to help labs streamline their daily operations.

Siemens Healthineers (Erlangen, Germany) has launched Chek-Stix Liquid Quality Control solutions - the latest innovation in its urinalysis portfolio. Chek-Stix UA Diptube Liquid QC contains both Level 1 (negative for all chemistry parameters and positive for hCG) and Level 2 (positive for all chemistry parameters and negative for hCG), packaged in one box. Both Level 1 and Level 2 diptube controls are ready-to-use liquid quality controls for use with the CLINITEK Status+ Analyzer, CLINITEK Advantus Analyzer, and visual-read urine strips.

Liquid-ready solution means less time spent on prepping quality control solution and more time on running patient samples. The product is barcode-enabled for quick, accurate data input and supports Siemens’ broad urine chemistry parameter menu. Validated for use with all Siemens’ urinalysis devices and reagents, the product has a shelf life of 22 months from the manufacture date.

Related Links:
Siemens Healthineers

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Plasma Control
Plasma Control Level 1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.